← Back to headlines
ImmunityBio Stock Loses 17% to Profit-Taking
ImmunityBio (IBRX) shares fell by 17% due to profit-taking after reaching an intra-day high.
26 Feb, 07:08 — 26 Feb, 07:08
Sources
Showing 1 of 1 sources
Related Stories
Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions
3h ago
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
5h ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
7h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
8h ago